Thrombosis in three postmenopausal women receiving testosterone therapy for low libido
Our hypothesis was that thrombosis occurring in postmenopausal women given testosterone (T) or testosterone-estradiol (TE) to improve libido was associated with a prothrombotic interaction between T or TE with underlying inherited procoagulants. In three previously healthy, postmenopausal, Caucasian...
Gespeichert in:
| Veröffentlicht in: | Women's health (London, England) England), 2013-07, Vol.9 (4), p.405-410 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 410 |
|---|---|
| container_issue | 4 |
| container_start_page | 405 |
| container_title | Women's health (London, England) |
| container_volume | 9 |
| creator | Glueck, Charles J Bowe, Dedrick Valdez, Alejandro Wang, Ping |
| description | Our hypothesis was that thrombosis occurring in postmenopausal women given testosterone (T) or testosterone-estradiol (TE) to improve libido was associated with a prothrombotic interaction between T or TE with underlying inherited procoagulants. In three previously healthy, postmenopausal, Caucasian women with no antecedent thrombosis and previously undiagnosed G20210A prothrombin gene heterozygosity, hyperhomocysteinemia and 4G4G homozygosity of the
gene, we describe central retinal vein thrombosis and osteonecrosis that developed at 16 days, 2 months and 11 months in the three cases, respectively, after T or TE therapy was started. Exogenous T or TE in postmenopausal women may be associated with thrombosis, speculatively when it is superimposed on underlying procoagulants. This small observational case series can serve as a starting point for a larger observational study with greater detail on patient history, serum T and estradiol levels, and detailed PCR and serologic assessment of thrombophilia and hypofibrinolysis. |
| doi_str_mv | 10.2217/whe.13.31 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_AFRWT</sourceid><recordid>TN_cdi_proquest_miscellaneous_1762381019</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A335874154</galeid><sage_id>10.2217_WHE.13.31</sage_id><sourcerecordid>A335874154</sourcerecordid><originalsourceid>FETCH-LOGICAL-c595t-7b96290226fd17262ede5e482ee24f9de7a3d231e0f58f7fb1a36281f71d5e6e3</originalsourceid><addsrcrecordid>eNqFkk1v1DAQhiMEoqVw4A8gSwgEh13ib-dYVYUiVeJS4Gg5znjXVWIHO2HVf49XWbaAKiEf7LGed-Ydj6vqJa7XhGD5YbeFNaZrih9Vp1gyvuK14I-PZy5Pqmc539Y1Ew3DT6sTQhURUtWn1bebbYpDG7PPyAc0bRMAGmOeBghxNHM2PdrFEqAEFvxPHzZogjwVAlIMUBSQzHiHXEyojzvU-9Z38Xn1xJk-w4vDflZ9_Xh5c3G1uv7y6fPF-fXK8oZPK9k2gjQ1IcJ1WBJBoAMOTBEAwlzTgTS0IxRD7bhy0rXYUEEUdhJ3HATQs-rdkndM8cdcfOnBZwt9bwLEOWssRekV17j5P0obxSgjihT09T_obZxTKI3sKaoU4xLfUxvTg_bBxSkZu0-qzynlSjLMWaHWD1BldTB4W17Q-XL_l-D9IrAp5pzA6TH5waQ7jWu9H7f-fnVZfGi6t_DqYHRuB-iO5O_5FuDNATDZmt4lE6zP95yUArOGF-7twmWzgT-6faAiX0A3T3OCbD0EC3qJigVvfYCjrnzMg-4XRlTPLQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1393884571</pqid></control><display><type>article</type><title>Thrombosis in three postmenopausal women receiving testosterone therapy for low libido</title><source>Sage Journals GOLD Open Access 2024</source><creator>Glueck, Charles J ; Bowe, Dedrick ; Valdez, Alejandro ; Wang, Ping</creator><creatorcontrib>Glueck, Charles J ; Bowe, Dedrick ; Valdez, Alejandro ; Wang, Ping</creatorcontrib><description>Our hypothesis was that thrombosis occurring in postmenopausal women given testosterone (T) or testosterone-estradiol (TE) to improve libido was associated with a prothrombotic interaction between T or TE with underlying inherited procoagulants. In three previously healthy, postmenopausal, Caucasian women with no antecedent thrombosis and previously undiagnosed G20210A prothrombin gene heterozygosity, hyperhomocysteinemia and 4G4G homozygosity of the
gene, we describe central retinal vein thrombosis and osteonecrosis that developed at 16 days, 2 months and 11 months in the three cases, respectively, after T or TE therapy was started. Exogenous T or TE in postmenopausal women may be associated with thrombosis, speculatively when it is superimposed on underlying procoagulants. This small observational case series can serve as a starting point for a larger observational study with greater detail on patient history, serum T and estradiol levels, and detailed PCR and serologic assessment of thrombophilia and hypofibrinolysis.</description><identifier>ISSN: 1745-5057</identifier><identifier>EISSN: 1745-5065</identifier><identifier>EISSN: 1745-5056</identifier><identifier>DOI: 10.2217/whe.13.31</identifier><identifier>PMID: 23826780</identifier><language>eng</language><publisher>London, England: Future Medicine Ltd</publisher><subject>Biological and medical sciences ; Blood and lymphatic vessels ; Blood clot ; Blood clots ; Cardiology. Vascular system ; Care and treatment ; central retinal vein thrombosis ; Diagnosis ; Disclosure ; Diseases of the osteoarticular system ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; Drug therapy ; Estradiol - adverse effects ; Estradiol - pharmacology ; Family medical history ; Female ; G20210A prothrombin gene mutation ; Gonadal Steroid Hormones - adverse effects ; Gonadal Steroid Hormones - pharmacology ; Health aspects ; Hip Joint ; Homocysteine ; Hormone therapy ; Hospitals ; Humans ; hyperhomocysteinemia ; Informed consent ; Libido - drug effects ; Medical sciences ; Men ; Methods ; Methylenetetrahydrofolate Reductase (NADPH2) - genetics ; Middle Aged ; Mutation ; osteonecrosis ; Osteonecrosis - chemically induced ; Osteonecrosis - genetics ; Plasminogen Activator Inhibitor 1 - genetics ; Postmenopausal women ; Postmenopause ; Proteins ; Prothrombin - genetics ; Retinal Vein Occlusion - chemically induced ; Retinal Vein Occlusion - genetics ; Sexual Dysfunctions, Psychological - drug therapy ; Studies ; Testosterone ; Testosterone - adverse effects ; Testosterone - pharmacology ; testosterone-estradiol ; Thrombosis ; Thrombosis - chemically induced ; Thrombosis - genetics ; Vascular bone diseases ; Womens health</subject><ispartof>Women's health (London, England), 2013-07, Vol.9 (4), p.405-410</ispartof><rights>2013 Future Medicine Ltd</rights><rights>2014 INIST-CNRS</rights><rights>COPYRIGHT 2013 Sage Publications Ltd. (UK)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c595t-7b96290226fd17262ede5e482ee24f9de7a3d231e0f58f7fb1a36281f71d5e6e3</citedby><cites>FETCH-LOGICAL-c595t-7b96290226fd17262ede5e482ee24f9de7a3d231e0f58f7fb1a36281f71d5e6e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.2217/WHE.13.31$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.2217/WHE.13.31$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,864,21966,27853,27924,27925,44945,45333</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.2217/WHE.13.31?utm_source=summon&utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27761495$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23826780$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Glueck, Charles J</creatorcontrib><creatorcontrib>Bowe, Dedrick</creatorcontrib><creatorcontrib>Valdez, Alejandro</creatorcontrib><creatorcontrib>Wang, Ping</creatorcontrib><title>Thrombosis in three postmenopausal women receiving testosterone therapy for low libido</title><title>Women's health (London, England)</title><addtitle>Womens Health (Lond)</addtitle><description>Our hypothesis was that thrombosis occurring in postmenopausal women given testosterone (T) or testosterone-estradiol (TE) to improve libido was associated with a prothrombotic interaction between T or TE with underlying inherited procoagulants. In three previously healthy, postmenopausal, Caucasian women with no antecedent thrombosis and previously undiagnosed G20210A prothrombin gene heterozygosity, hyperhomocysteinemia and 4G4G homozygosity of the
gene, we describe central retinal vein thrombosis and osteonecrosis that developed at 16 days, 2 months and 11 months in the three cases, respectively, after T or TE therapy was started. Exogenous T or TE in postmenopausal women may be associated with thrombosis, speculatively when it is superimposed on underlying procoagulants. This small observational case series can serve as a starting point for a larger observational study with greater detail on patient history, serum T and estradiol levels, and detailed PCR and serologic assessment of thrombophilia and hypofibrinolysis.</description><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Blood clot</subject><subject>Blood clots</subject><subject>Cardiology. Vascular system</subject><subject>Care and treatment</subject><subject>central retinal vein thrombosis</subject><subject>Diagnosis</subject><subject>Disclosure</subject><subject>Diseases of the osteoarticular system</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>Drug therapy</subject><subject>Estradiol - adverse effects</subject><subject>Estradiol - pharmacology</subject><subject>Family medical history</subject><subject>Female</subject><subject>G20210A prothrombin gene mutation</subject><subject>Gonadal Steroid Hormones - adverse effects</subject><subject>Gonadal Steroid Hormones - pharmacology</subject><subject>Health aspects</subject><subject>Hip Joint</subject><subject>Homocysteine</subject><subject>Hormone therapy</subject><subject>Hospitals</subject><subject>Humans</subject><subject>hyperhomocysteinemia</subject><subject>Informed consent</subject><subject>Libido - drug effects</subject><subject>Medical sciences</subject><subject>Men</subject><subject>Methods</subject><subject>Methylenetetrahydrofolate Reductase (NADPH2) - genetics</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>osteonecrosis</subject><subject>Osteonecrosis - chemically induced</subject><subject>Osteonecrosis - genetics</subject><subject>Plasminogen Activator Inhibitor 1 - genetics</subject><subject>Postmenopausal women</subject><subject>Postmenopause</subject><subject>Proteins</subject><subject>Prothrombin - genetics</subject><subject>Retinal Vein Occlusion - chemically induced</subject><subject>Retinal Vein Occlusion - genetics</subject><subject>Sexual Dysfunctions, Psychological - drug therapy</subject><subject>Studies</subject><subject>Testosterone</subject><subject>Testosterone - adverse effects</subject><subject>Testosterone - pharmacology</subject><subject>testosterone-estradiol</subject><subject>Thrombosis</subject><subject>Thrombosis - chemically induced</subject><subject>Thrombosis - genetics</subject><subject>Vascular bone diseases</subject><subject>Womens health</subject><issn>1745-5057</issn><issn>1745-5065</issn><issn>1745-5056</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>QXPDG</sourceid><recordid>eNqFkk1v1DAQhiMEoqVw4A8gSwgEh13ib-dYVYUiVeJS4Gg5znjXVWIHO2HVf49XWbaAKiEf7LGed-Ydj6vqJa7XhGD5YbeFNaZrih9Vp1gyvuK14I-PZy5Pqmc539Y1Ew3DT6sTQhURUtWn1bebbYpDG7PPyAc0bRMAGmOeBghxNHM2PdrFEqAEFvxPHzZogjwVAlIMUBSQzHiHXEyojzvU-9Z38Xn1xJk-w4vDflZ9_Xh5c3G1uv7y6fPF-fXK8oZPK9k2gjQ1IcJ1WBJBoAMOTBEAwlzTgTS0IxRD7bhy0rXYUEEUdhJ3HATQs-rdkndM8cdcfOnBZwt9bwLEOWssRekV17j5P0obxSgjihT09T_obZxTKI3sKaoU4xLfUxvTg_bBxSkZu0-qzynlSjLMWaHWD1BldTB4W17Q-XL_l-D9IrAp5pzA6TH5waQ7jWu9H7f-fnVZfGi6t_DqYHRuB-iO5O_5FuDNATDZmt4lE6zP95yUArOGF-7twmWzgT-6faAiX0A3T3OCbD0EC3qJigVvfYCjrnzMg-4XRlTPLQ</recordid><startdate>20130701</startdate><enddate>20130701</enddate><creator>Glueck, Charles J</creator><creator>Bowe, Dedrick</creator><creator>Valdez, Alejandro</creator><creator>Wang, Ping</creator><general>Future Medicine Ltd</general><general>SAGE Publications</general><general>Future Medicine</general><general>Sage Publications Ltd. (UK)</general><general>Sage Publications Ltd</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7R6</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>EHMNL</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQGEN</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>QXPDG</scope><scope>7X8</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20130701</creationdate><title>Thrombosis in three postmenopausal women receiving testosterone therapy for low libido</title><author>Glueck, Charles J ; Bowe, Dedrick ; Valdez, Alejandro ; Wang, Ping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c595t-7b96290226fd17262ede5e482ee24f9de7a3d231e0f58f7fb1a36281f71d5e6e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Blood clot</topic><topic>Blood clots</topic><topic>Cardiology. Vascular system</topic><topic>Care and treatment</topic><topic>central retinal vein thrombosis</topic><topic>Diagnosis</topic><topic>Disclosure</topic><topic>Diseases of the osteoarticular system</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>Drug therapy</topic><topic>Estradiol - adverse effects</topic><topic>Estradiol - pharmacology</topic><topic>Family medical history</topic><topic>Female</topic><topic>G20210A prothrombin gene mutation</topic><topic>Gonadal Steroid Hormones - adverse effects</topic><topic>Gonadal Steroid Hormones - pharmacology</topic><topic>Health aspects</topic><topic>Hip Joint</topic><topic>Homocysteine</topic><topic>Hormone therapy</topic><topic>Hospitals</topic><topic>Humans</topic><topic>hyperhomocysteinemia</topic><topic>Informed consent</topic><topic>Libido - drug effects</topic><topic>Medical sciences</topic><topic>Men</topic><topic>Methods</topic><topic>Methylenetetrahydrofolate Reductase (NADPH2) - genetics</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>osteonecrosis</topic><topic>Osteonecrosis - chemically induced</topic><topic>Osteonecrosis - genetics</topic><topic>Plasminogen Activator Inhibitor 1 - genetics</topic><topic>Postmenopausal women</topic><topic>Postmenopause</topic><topic>Proteins</topic><topic>Prothrombin - genetics</topic><topic>Retinal Vein Occlusion - chemically induced</topic><topic>Retinal Vein Occlusion - genetics</topic><topic>Sexual Dysfunctions, Psychological - drug therapy</topic><topic>Studies</topic><topic>Testosterone</topic><topic>Testosterone - adverse effects</topic><topic>Testosterone - pharmacology</topic><topic>testosterone-estradiol</topic><topic>Thrombosis</topic><topic>Thrombosis - chemically induced</topic><topic>Thrombosis - genetics</topic><topic>Vascular bone diseases</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Glueck, Charles J</creatorcontrib><creatorcontrib>Bowe, Dedrick</creatorcontrib><creatorcontrib>Valdez, Alejandro</creatorcontrib><creatorcontrib>Wang, Ping</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>GenderWatch</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>UK & Ireland Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest Women's & Gender Studies</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Diversity Collection</collection><collection>MEDLINE - Academic</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Women's health (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Glueck, Charles J</au><au>Bowe, Dedrick</au><au>Valdez, Alejandro</au><au>Wang, Ping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thrombosis in three postmenopausal women receiving testosterone therapy for low libido</atitle><jtitle>Women's health (London, England)</jtitle><addtitle>Womens Health (Lond)</addtitle><date>2013-07-01</date><risdate>2013</risdate><volume>9</volume><issue>4</issue><spage>405</spage><epage>410</epage><pages>405-410</pages><issn>1745-5057</issn><eissn>1745-5065</eissn><eissn>1745-5056</eissn><abstract>Our hypothesis was that thrombosis occurring in postmenopausal women given testosterone (T) or testosterone-estradiol (TE) to improve libido was associated with a prothrombotic interaction between T or TE with underlying inherited procoagulants. In three previously healthy, postmenopausal, Caucasian women with no antecedent thrombosis and previously undiagnosed G20210A prothrombin gene heterozygosity, hyperhomocysteinemia and 4G4G homozygosity of the
gene, we describe central retinal vein thrombosis and osteonecrosis that developed at 16 days, 2 months and 11 months in the three cases, respectively, after T or TE therapy was started. Exogenous T or TE in postmenopausal women may be associated with thrombosis, speculatively when it is superimposed on underlying procoagulants. This small observational case series can serve as a starting point for a larger observational study with greater detail on patient history, serum T and estradiol levels, and detailed PCR and serologic assessment of thrombophilia and hypofibrinolysis.</abstract><cop>London, England</cop><pub>Future Medicine Ltd</pub><pmid>23826780</pmid><doi>10.2217/whe.13.31</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | ISSN: 1745-5057 |
| ispartof | Women's health (London, England), 2013-07, Vol.9 (4), p.405-410 |
| issn | 1745-5057 1745-5065 1745-5056 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1762381019 |
| source | Sage Journals GOLD Open Access 2024 |
| subjects | Biological and medical sciences Blood and lymphatic vessels Blood clot Blood clots Cardiology. Vascular system Care and treatment central retinal vein thrombosis Diagnosis Disclosure Diseases of the osteoarticular system Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Drug therapy Estradiol - adverse effects Estradiol - pharmacology Family medical history Female G20210A prothrombin gene mutation Gonadal Steroid Hormones - adverse effects Gonadal Steroid Hormones - pharmacology Health aspects Hip Joint Homocysteine Hormone therapy Hospitals Humans hyperhomocysteinemia Informed consent Libido - drug effects Medical sciences Men Methods Methylenetetrahydrofolate Reductase (NADPH2) - genetics Middle Aged Mutation osteonecrosis Osteonecrosis - chemically induced Osteonecrosis - genetics Plasminogen Activator Inhibitor 1 - genetics Postmenopausal women Postmenopause Proteins Prothrombin - genetics Retinal Vein Occlusion - chemically induced Retinal Vein Occlusion - genetics Sexual Dysfunctions, Psychological - drug therapy Studies Testosterone Testosterone - adverse effects Testosterone - pharmacology testosterone-estradiol Thrombosis Thrombosis - chemically induced Thrombosis - genetics Vascular bone diseases Womens health |
| title | Thrombosis in three postmenopausal women receiving testosterone therapy for low libido |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T19%3A18%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thrombosis%20in%20three%20postmenopausal%20women%20receiving%20testosterone%20therapy%20for%20low%20libido&rft.jtitle=Women's%20health%20(London,%20England)&rft.au=Glueck,%20Charles%20J&rft.date=2013-07-01&rft.volume=9&rft.issue=4&rft.spage=405&rft.epage=410&rft.pages=405-410&rft.issn=1745-5057&rft.eissn=1745-5065&rft_id=info:doi/10.2217/whe.13.31&rft_dat=%3Cgale_AFRWT%3EA335874154%3C/gale_AFRWT%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1393884571&rft_id=info:pmid/23826780&rft_galeid=A335874154&rft_sage_id=10.2217_WHE.13.31&rfr_iscdi=true |